NYSE · INSP
Inspire Medical Systems, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for INSP: Nov 02, 2026
Inspire Medical Systems, Inc. Common Stock is expected to report earnings on 11/02/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 5 analysts' forecasts, the consensus EPS forecast for the quarter is $0.1. The reported EPS for the same quarter last year was $0.38.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.10 | $0.14 | $0.08 | 5 |
| Dec 2026 | $0.88 | $0.95 | $0.83 | 4 |
| Mar 2027 | $0.17 | $0.40 | $-0.06 | 2 |
| Jun 2027 | $0.23 | $0.41 | $0.05 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · RTTNews- Zacks · Oct 23, 10:37 AM EDTINSP Stock Gains 47.8% in Three Months: What's Driving the Rally?Inspire Medical Systems gains 47.8% in three months as improved reimbursement clarity, an earnings beat, $30 million in annual savings and new CPT codes boost recovery prospects.
- Zacks · Oct 19, 9:00 AM EDTHere's How Tempus AI Demonstrates Improving Operating LeverageTEM shows improving operating leverage as Q2 revenues jump 22%, adjusted EBITDA turns positive and lower interest costs support its free cash flow goal.
- Fintel · Oct 7, 3:58 PM EDTBarclays Initiates Coverage of Inspire Medical Systems at UnderweightFintel reports that on October 7, 2026, Barclays initiated coverage of Inspire Medical Systems (NYSE:INSP) (DB:2DR) with a Underweight recommendation.Inspire Medical Systems, Inc., based in the United States, operates within the healthcare sector, specifically focusing on medical
- Zacks · Oct 5, 10:52 AM EDTInspire Medical Gains New CPT Codes for Hypoglossal Nerve StimulationINSP gains new Category I CPT codes for Inspire V procedures, creating a dedicated coding framework effective Jan. 1, 2028.
- RTTNews · Oct 2, 12:56 AM EDTInspire Secures AMA Approval For New Hypoglossal Nerve Stimulation Codes(RTTNews) – Inspire Medical Systems, Inc. (INSP) announced that American Medical Association CPT Editorial Panel has approved a new set of Current Procedural Terminology (CPT) codes covering hypoglossal nerve stimulation procedures that include the company's Inspire V system. The
- RTTNews · Oct 2, 12:21 AM EDTInspire Wins AMA Approval For New CPT Codes Covering Inspire V System(RTTNews) – CPT Editorial Panel approved new Category I CPT codes that specifically describe and include the Inspire V hypoglossal nerve stimulation system. The new codes are scheduled to take effect on January 1, 2028.
- Zacks · Sep 23, 11:09 AM EDTHere's Why You Should Retain INSP Stock in Your Portfolio for NowInspire Medical is navigating a major product transition as clinical evidence, patient access efforts and reimbursement progress support growth prospects.
- Zacks · Sep 22, 10:00 AM EDTQuest Diagnostics Study Finds High Tick-Borne Disease Co-ExposureDGX study finds nearly one-third of Lyme-seropositive patients had antibodies to another tick-borne pathogen, highlighting broader testing needs.
- Zacks · Sep 21, 9:33 AM EDTOPK Stock Climbs 32.5% YTD: What's Driving the Rally in 2026?OPKO Health is gaining on pharmaceutical growth, a broad clinical pipeline, strategic partnerships and fresh non-dilutive financing.
- Zacks · Sep 18, 10:35 AM EDTWaters Launches BD FACSDiscover A7 for Advanced Flow CytometryWAT launches the BD FACSDiscover A7 globally, bringing advanced spectral flow cytometry, automation and standardized workflows to research labs.
- Zacks · Sep 18, 9:21 AM EDTReasons to Add West Pharmaceutical Stock to Your Portfolio NowWest Pharmaceutical's biologics exposure, Annex 1 projects and delivery-device growth support prospects despite near-term headwinds.
- Zacks · Sep 17, 11:22 AM EDTReasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for NowXRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Inspire Medical Systems, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.